The Impact of Non-HDL-C/HDL-C Ratio on Depression Risk in Obese Adults

The non-HDL-C/HDL-C ratio (NHHR) is emerging as a significant indicator of metabolic abnormalities, particularly in assessing cardiovascular risk. Research indicates that NHHR may provide a more comprehensive evaluation compared to traditional lipid markers. Studies have shown that abnormal NHHR levels correlate with increased risks of conditions such as hypertension and non-alcoholic fatty liver disease. However, its relationship with mental health, specifically depression in obese individuals, is still under investigation.

High Non-HDL-C/HDL-C Ratio in Adults With Obesity Increases Depression RiskTransdermal hormone therapy linked to lower rates of anxiety, depression in postmenopausal womenCardiovascular Disease in Menopause: Confronting the Monolithic Health Curve

A recent cross-sectional analysis utilized national data from 2013 to 2023, involving 13,991 adults to explore the association between NHHR and depressive symptoms. The study employed the Patient Health Questionnaire-9 (PHQ-9) to assess depression, revealing a mean NHHR of 2.97 and a depression prevalence of 10.33% among participants. The findings indicated that each 1-unit increase in NHHR was linked to a 7% higher risk of depression in the unadjusted model, escalating to a 12% increase when demographic variables were considered.

High Non-HDL-C/HDL-C Ratio in Adults With Obesity Increases Depression RiskTransdermal hormone therapy linked to lower rates of anxiety, depression in postmenopausal womenTechnology Networks

The study also examined the mediating role of body mass index (BMI) in the NHHR-depression relationship. Results showed that BMI partially mediated this association, accounting for approximately 15.81% of the total effect. This suggests that higher NHHR levels not only directly influence depression risk but also do so indirectly through their impact on obesity.

High Non-HDL-C/HDL-C Ratio in Adults With Obesity Increases Depression RiskTransdermal hormone therapy linked to lower rates of anxiety, depression in postmenopausal womenAPOE ?4 and Inflammation Amplify Risk for Memory Decline in Women with Earlier Menopause

As obesity rates continue to rise globally, identifying reliable indicators like NHHR is crucial for improving patient health outcomes. The study emphasizes the potential for pharmacists and healthcare providers to utilize NHHR calculations in managing dyslipidemia and obesity, thereby informing treatment strategies for both conditions. Early identification of elevated NHHR could facilitate targeted interventions to mitigate the dual burden of obesity and depression.

High Non-HDL-C/HDL-C Ratio in Adults With Obesity Increases Depression Risk

While the study presents compelling associations, it calls for further validation through longitudinal research to better understand the underlying mechanisms linking lipid metabolism abnormalities to depression. The authors advocate for future studies to explore these relationships in high-risk populations, aiming to develop targeted intervention strategies.

High Non-HDL-C/HDL-C Ratio in Adults With Obesity Increases Depression Risk

The relationship between NHHR and depression in obese adults underscores the importance of comprehensive health assessments that include metabolic indicators. As healthcare providers seek to address the intertwined challenges of obesity and mental health, NHHR may serve as a valuable tool in guiding treatment and prevention efforts. Continued research is essential to refine these associations and enhance clinical practices for managing obesity-related mental health issues.

High Non-HDL-C/HDL-C Ratio in Adults With Obesity Increases Depression Risk